Huntington’s Disease Treatment Market is expected to reach USD 2.9 Billion rise steadily at a CAGR of 17.7% during forecast period of 2023-2032. Huntington’s disease (HD) is a debilitating neurodegenerative disorder with a genetic basis, characterized by progressive motor dysfunction, cognitive decline, and psychiatric symptoms. Despite its rarity, affecting about 1 in 10,000...